Botfet / Company detail

MEDP

universe

Medpace Holdings, Inc.

biotech

Moat score42out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic67.9%

Gross Margin30.1%

Revenue Cagr22.0%

Fcf Conversion151.2%

Fcf Yield3.6%

Interest Coverage0.0x

Market Cap B$18.9B

Pe36.5

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant42

Why it may endure

Moat breakdown

Quant: 42 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power8

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener